SoVote

Decentralized Democracy

House Hansard - 335

44th Parl. 1st Sess.
June 19, 2024 02:00PM
  • Jun/19/24 5:49:21 p.m.
  • Watch
The second petition is with respect to pulmonary arterial hypertension, which is a rare, life-threatening condition. Recent results from the STELLAR clinical trials offer new hope for patients, and the petitioners are calling on the Government of Canada to urge Health Canada to approve sotatercept, a significant milestone in the treatment option for PAH, without further delay. The third petition is on the same topic of pulmonary arterial hypertension. The petition talks about patients needing timely access to new therapies. Therefore, the petitioners are calling on the federal government to allocate funding now to the provinces so that new treatments can be made available quickly to Canadians living with this rare disease and that the federal government have a holistic approach to rare diseases that includes early detection and prevention, timely and equitable access to evidence-based care, enhanced community support, and the promotion of innovative research.
148 words
  • Hear!
  • Rabble!
  • star_border